"Hulamin overcame a difficult first half to record an improvement in earnings for the year under review.
We look forward to improve our operating performance further in 2013, underpinned by continued delivery
from our manufacturing excellence programme. Market conditions however remain challenging. A gradual
improvement in demand is anticipated as the world economic outlook improves."